Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 12:56 AM
Ignite Modification Date:
2025-12-25 @ 12:56 AM
NCT ID:
NCT07256067
Eligibility Criteria:
Inclusion Criteria:
* Adults aged 35 to 55 years
* Diagnosis of Systemic Lupus Erythematosus (SLE) based on the 2010 Revised American College of Rheumatology (ACR) or SLICC classification criteria.
* Self-reported pain score of ≥4 on a 10 cm Visual Analogue Scale (VAS).
* Receiving stable doses of Disease Modifying Anti-Rheumatic Drugs (DMARDs), biological therapy, and/or prednisone ≤10 mg/day, with no changes in dose within 28 days prior to baseline.
* They have been referred by a rheumatologist.
Exclusion Criteria:
* Diagnosis of fibromyalgia or any other overlapping chronic pain syndrome.
* Use of pacemakers, implantable cardioverter defibrillators (ICDs), or other electronic implants.
* Current pregnancy or breastfeeding.
* History of epilepsy or seizure disorders.
Healthy Volunteers:
False
Sex:
FEMALE
Minimum Age:
35 Years
Maximum Age:
55 Years
Study:
NCT07256067
Study Brief:
Protocol Section:
NCT07256067